StockData
Humacyte, Inc. logo

Humacyte, Inc. (HUMA) stock

HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.50−0.04 (-7.27%)

Close on Nov 17, 2026Market cap $139.18MP/E –Yield –

Humacyte price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Humacyte's price to book ratio was 5.3× on Nov 11, 2026, against 59.8× a year earlier. Over the last 4 years it ranged from 1.8× to 69.2×, with a median of 6.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.3×−59.2
2025Oct 31, 202564.4×+21.4
2024Jul 31, 202443.1×+35.1
2023Dec 29, 20237.9×+6.1
2022Dec 30, 20221.8×−8.0
2021Dec 31, 20219.8×–

More Humacyte figures

See a number that looks wrong?